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INTRODUCTION
    Chronic  pancreatitis  is  a  relentlessly  progressive  fibroinflammatory 
process,  resulting in  various amounts  of  destruction of endocrine  and exocrine 
elements, which may eventually lead to pancreatic insufficiency.
Abdominal pain which is excruciating and recurrent is dominant feature of 
chronic  pancreatitis  that  initially  brings  most  of  the  patients  to  physician’s 
attention.  The pathogensis of pancreatic pain is often multifactorial and explains 
why not all patients respond to same mode of therapy.
In contrast  to the quantitatively huge interest  stands.   The fact  that  basic 
problem concerning the disease, the initial steps, the propagation, the mechanisms 
are still unsolved.  This obvious defect in knowledge and understanding of what 
really  going  on,  when  individual  get  a  chronic  pancreatitis  bears  a  profound 
influence on therapeutic approach to the disease.
AIM OF THE STUDY
1. To study the epidemiological patterns in relation to age, sex and 
place.
2. To study the different etiological factors and pattern of clinical 
presentations.
3. To  study  the  incidence  of  the  Chronic  pancreatitis  at  GRH, 
Madurai
4. To  know the  outcome  and  response  of  the  surgical  drainage 
procedure.
REVIEW OF LITERATURE
1. Surgical management of chronic pancreatitis :  Long term result in 141 
patient. Br.J. Surg 1988.
Mannell A ;  Adson MA ; Mcllrath DC ; IIstrup DM ; Department of 
Surgery Mayo Clinic Rochester, Minnesota
• 141 patient were operated for chronic pancreatitis at Mayo clinic.  The main 
indication  was  pancreatic  pain  and  choice  of  operation  was  based  on 
anatomical abnormalities in the gland.
• Mean follow up period – 8.5 years
• Number of patient operated – 141 patients
• Conclusion 
– 77% of operated patient had lasting pain relief
– Longitudinal pancreatico jejunostomy in those  with dilated duct and 
whipple operation for disease of pancreatic head gave good results.
2. Local resection of the head of the pancreas combined with longitudinal 
pancreatico-jejunostomy in the management of patients with chronic 
pancreatitis. 
Ann Surg 1994, Frey CF :  Amikura K, Department of Surgery, University 
of California, Davis Medical Centre, Sacramento.
Material  -The operation was performed on 50 patients, pain relief, endocrine and 
exocrine insufficiency and weight gain were assessed.
Conclusion -  The LR – LPJ provides good pain relief with modest increase in 
endocrine and exocrine insufficiency and a significant increase in weight.  Even 
when relieved of pain, patients seldom return to the work force.
3. Pain relapse in the first 10 years of chronic pancreatitis, An. J Surg 1996.
Talamani G ; Bassi C, Falconi ; Sartonin ; Salvia R ; DiFrancesco V ; 
Frulloni  L  ;  Vaona  B  ;  Bovo  P  ;  Vantin  I  ;  Pederzoli  P  ;  Cavallini  G. 
Department of Medicine University of Verora, Italy.
To  evaluate  whether  the  annual  number  of  pain  relapse  of  chronic 
pancreatitis correlated with sex, type of pancreatitis,  drinking and smoking and 
type of surgery .
Length of follow up - 10 yrs
Number of patients - 2,034 / year
Conclusion  -   Regardless  of  surgical  treatment  patients  should  be  advised  to 
reduce both their alcohol intake and cigarette smoking.
4.   Chronic  Pancreatitis,  Paul  Georg  Lankisch  MD,  sur  Opin 
Gastroenterology 2007.
Abstract :  Purpose of Review is to focuss on the most important new observations 
in chronic pancreatitis.
Recent findings –
• Superiority of Surgery compared with endotherapy for long term pain relief.
• Smoking enhances the risk of chronic pancreatitis
• New insights in Autoimmune pancreatitis
Study :
Amsterdam group conducted Randomized trial, Comparing endoscopic and 
surgical drainage of the pancreatic duct.
39 -  patients participated
19 – endoscopic treatment
20 – surgical drainage procedure
Follow up period – 24 months
Result :
Complete or partial pain relief
32%  -  Endoscopic group
75%  - Surgery group
5. Surgical Management of CP:  Gourgiotis  S, 
Germanos  S,  Ridolfini  MP,  Department  of  hepatobiliary  and  pancreatic 
surgery. Royal London Hospital London, UK. Hepatobilary pancreatic Dis 
Int 2007 Apr 6.
Background : During  the  last 
decade increasing knowledge about pathophysiology of CP, improved results of 
major pancreatic resections and integration of sophisticated diagnostic methods in 
clinical practice resulted in significant changes in surgery for CP.
Conclusion : Surgical  procedure 
provide long term pain relief a good post operative quality of life with preservation 
of endocrine and exocrine  function.   In  addition   to  available  results  from 
randomized controlled trials, new studies are needed to determine which procedure 
is most effective for the management of patient with CP.
6.  Extended drainage versus resection in Surgery for CP :   A prospective 
randomized  trail  comparing  LPJ  +  Local  pancreatic  head  excision  with 
pylons preserving pancreatoduodenectomy.
Ann Sug  1998,  Dec,   Izbicki  JR,  Bloechle  C,  Broering  DC,  Knoefel  WT, 
Kuechler  T,  Broelsch CI.  Department  of  Surgery University  of  Hamburg, 
Germany.
To analyse the efficacy of LPJ – LPHI & PPPD
Number of patients – 61 patients were randomly allocated
Conclusion: – Both procedures are equally effective in terms of pain relief and 
definitive control of complications affecting adjacent organ, but extended drainage 
procedure provides better quality of life.
7.  Comparative RCT between endoscopic treatment with surgical treatment 
in painful obstructive CP.  Dite et al, Endoscopy 2003.
Number of patients - 140
Surgery  -  80% Resection,  20% drainage
Endoscopy – 52% sphincterotomy and 
Stenting, 23% stone removal, 
Follow up period – 5 yrs
Conclusion :
Pain relief after surgery is superior to endotherapy in patient with painful 
obstructive CP.
8.  Chronic pancreatitis  :  A prospective nationwide study of 1086 subjects 
from India
Balakrishnan  V,  Unnikrishnan  AG,  Thomas  V,  Choidhini  Veera  raju  P, 
Singh IP, Garg P, Pai CG, Devi RN, Bhasin D, Jayanthi D, Premalatha N, 
Chacko A…, Amitha Institute of Medical Science, Cochin India, Sep 2008 : 
pub Med.
Study   :   Prospective  nationwide  study  of  risk  factors  and  clinical  profile  of 
Chronic pancreatitis
Setting :  32 major centres from all over India contributed data on 1,086  patients.
Outcome Measures :  Risk factors, Clinical features, complications and treatment 
of Chronic pancreatitis.
Conclusion :  In this first nationwide prospective study of Chronic pancreatitis in 
India, Idiopathic Chronic pancreatitis was the most common form, followed by 
alcoholic  pancreatitis.   The  classical  form  of  tropical  Chronic  pancreatitis  is 
becoming less common.
9. Comparative  study  of  the  clinical  profiles  of  Alcoholic  chronic 
pancreatitis and tropical Chronic pancreatitis in Tamilnadu, South India.
Chari ST, Mohan V, Jeyanth V, Snehalatha C, Malathis,  Viswanathan M, 
Madanagopalan N.  Department of Digestive Health and Disease Government 
Peripheral Hospital, Madras, India Pub Med :  Pancreas : 1992.
Number of patients - 50
Conclusion  :   TCP and ACP  have distinct clinical profile and it is possible that 
some environments factors may hasten the progress of ACP in the tropics.
HISTORY OF PANCREATIC ANATOMY 
The pancreas was first mentioned in the writing of Eristratos (310-250 BC) and 
given its name by Rufus of Ephesus (Crica 1040). The name pancreas (Greak Pan- 
all,  kreas-flesh almost) was used because the organ contain neither cartilage or 
bone.  Its main duct was described by Wirsung in 1642, where the enlargement of 
the duct at its junction with the CBD and its projection in to the duodenum as a 
papilla were first described by Vater in 1720.  Santorini in 1734 described  the 
accessory duct that bears his name.  It was only after demonstration of digestive 
enzymes by Claude Bernard in 1850 that the pancreas became a complete organ 
with an important function and thus a worthy object of study.
Inspite of the apparent accessibility of the pancreas, a number of complex 
relations combines to make its surgical removal difficult.  In 1899 Halsted was 
first to successfully remove the head of pancreas and portion of duodenum for 
ampullary  carcinoma.   Several  surgeons  developed  two  staged  operations,  for 
removal of head of pancreas.  These efforts culminated in 1940 with one stage 
operation of whipple.
Sir Andrew Watt kay wrote in 1978, “For me, the tiger country is removal of 
the pancreas.  The anatomy is very complex and one counters anomalies”.
Location :
The  pancreas  lies  posterior  to  the  stomach  and  lesser  omentum   in  the 
retroperitoneum of the upper abdomen.  It extends obliquely rising slightly as it 
passes from the medial edge of duodenal C loop to the hilum of the spleen.  It lies 
anterior to the inferior venacava, aorta, splenic vein and left adrenal gland.
Regions :
Pancreas is divided into four regions. The head and uncinate process, neck, 
body and tail.  The head lies within the duodenal loop and its uncinate process 
extends posteriorly and medially to lie behind the  Superior mesenteric vein and 
SMA.  The neck of the gland extends medially from the head to lie anterior to 
these vessels.  The body extends laterally from the neck toward the spleen,  where 
as the tail extends into the splenic hilum.
Blood supply and Lymphnodes :
Both  the  celiac  trunk  and  the  SMA  provide  the  arterial  supply  to  the 
pancreas.  Variations are  common,  but  for  the  most  part,  the  body and tail  are 
supplied  by  branch of  the  splenic  artery,  where  as  head and uncinate  process 
receive  their  supply  through  arcade  originating  form  the  hepatic  and 
gastroduodenal branch of celiac artery and from the first branch of the SMA.
Venous drainage is to the splenic vein, SMV and portal vein.  The pancreas 
is drained by multiple lymph node groups.  The major drainage of pancreatic head 
and  uncinate  process  is  to  the  subpyloric,  portal,  mesenteric,  mesocolic  and 
aortocaval  node.   The  pancreatic  body  and  tail  for  the  most  part  are  drained 
through  nodes  in  the  celiac,  aortocaval,  mesenteric  and  mesocolic  groups  and 
through nodes in the splenic hilum.
Innervation :
The  pancreas  is  innervated  by  both  sympathetic  and  para  sympathetic 
components of the autonomic nervous system.  The principal and possibly only, 
pathway for pancreatic pain involves nociceptive fibers arising in the pancreas. 
They  pass  through  the  celiac  ganglia  to  form  the  greater,  lesser  and  least 
splanchnic  nerves  that  pass  to  cell  bodies  in  the  thoracic  sympathetic  chain. 
Efferent visceral motor supply to the pancreas is provided by both the sympathetic 
and  parasympathetic  systems.   The  latter  involves  preganglionic  fibers  arising 
form cell bodies in the vagal nuclei that travel through the posterior vagal trunk to 
the  celiac  plexus.  Postganglionic  fibers  then  innervate  pancreatic  islets,  acini, 
ducts and blood vessels.  In general,  the nerves of the pancreas travel with the 
blood vessels supplying the organ.
Ducts :
The  main  pancreatic  duct,  or  duct  of  Wirsung  arising  in  the  tail  of  the 
pancreas and terminates at the papilla of vater in the duodenum.  It crosses the 
vertebral column between T12 and L2.  Within the body and tail of the pancreas, 
the duct lies slightly caphaled  to a line drawn midway between the superior and 
inferior edges.  The duct is also more posterior than anterior. In adults, the duct 
within the  head  measures 3.1  to  4.8  mm in diameter  and gradually  tapers  to 
measure 0.9 to 2.4 mm in the tail.  With age, the duct diameter can increase.  The 
duct of santorini ie. the minor or accessory  pancreatic duct is smaller than the 
main duct.   It  extends from the main duct to enter the duodenum at the lesser 
papilla. That Papilla lies about 2 cm proximal and slightly anterior to the major 
papilla.
EMBRYOLOGY
Organagenesis :
During  the  4th week  of  gestation,  two  endodermal  buds  arise  from  the 
duodenum ;  the  hepatic  diverticulum,  which  is  desired  to  form the  liver,  gall 
bladder and bile ducts, and the dorsal pancreatic bud that forms the body and tail 
of the pancreas.  On the 32nd day of gestation, this hepatic diverticulum gives rise 
to a ventral pancreatic bud that eventually develops into the uncinate process and 
inferior  part  of  the  head  of  the  pancreas.   The  dorsal  pancreatic  bud  extends 
transversely  across  the  abdomen  to  lies  anterior  to  the  portal  and  mesenteric 
vessels. With time  and as the duodenum  rotates to form a C loop configuration 
the ventral pancreas and distal bile duct undergo clockwise rotation around the 
back of duodenum to finally, lie on the medial side of the duodenum, inferior and 
slightly posterior to the dorsal pancreas and posterior to the portal and mesenteric 
vessels.  On the 37th day of gestation, the two pancreatic buds fuse and in 90% of 
individuals, their duct system also join.
HISTOLOGY 
The  mature  pancreas  is  an  endocrine  organ  made  up  of  the  islets  of 
Langerhans  and an  exocrine  organ consisting  of  acinar  and ductal  cells.   The 
acinar cels, so named because they are clustered like grapes on the stem of a vine, 
discharge their secretions into a centrally located acinar space that communicates 
with the major pancreatic duct.  Most of the cells in the pancreas are acinar cells 
and duct cells make up only 5% of pancreatic mass. Histologically, acinar cells 
have  a  high  content  of  endoplasmic  reticulum  and  an  abundance  of  apically 
located eosinophilic zymogen granules.  The cells lining the main pancreatic duct 
are table columnar cells and many contain mucin granules.  With progression form 
the large ducts to the smaller intralobular and interlobular ducts the lining cells 
become flatter, assuming a cuboidal configuration, and the mucin granules are no 
longer seen.  Centroacinar cells located at the junction between ducts and acini 
resemble acinar cells in size and shape but lacks Zymogen granules.
PHYSIOLOGY
About  2.5  liters  of  clear,  colorless,  bicarbonate-rich  pancreatic  juice, 
containing 6 to 20g of protein, is secreted by the human pancreas each day.  It 
plays a critical role in duodenal alkalinization and in food digestion.
Protein Secretion :
With the possible exception of the lactating mammary gland, the exocrine 
pancreas synthesizes protein at a greater rate, per gram of tissue, than any other 
organ.  More than 90% of that protein consists of digestive enzymes.  Most of the 
digestive  enzymes  are  synthesized  and  secreted  by  acinar  cells  as  inactive 
proenzymes or zymogens that, in health, are activated only after they reach the 
duodenum where enterokinase activates trypsinogen and the trypsin catalyses the 
activation of the other zymogens.  Some of the pancreatic digestive enzymes are 
synthesized and secreted in their active forms without the need for an activation 
step (eg.  Amylase,  lipase,  ribonuclease).   Acinar cells also synthesize proteins, 
including enzymes, that are not destined for secretion but, rather, are intended for 
use within the acinar cell itself.  Examples of this latter group of proteins include 
the various structural proteins and lysosomal hydrolases.
Newly synthesized proteins are assembled within the cisternae of the rough 
endoplasmic reticulum and transported to the Golgi, where they are modified by 
glycosylation.  Those destined for secretion pass through the Golgi stacks and are 
packaged within condensing vacuoles that evolve into zymogen granules as they 
migrate  toward the luminal surface of the acinar cell.   By a process involving 
membrane  fusion  and  fission,  the  contents  of  the  zymogen  granules  are  then 
released into the acinar lumen.  Other proteins that are not destined for secretion 
are segregated away from the secretory pathway as they pass through the Golgi, 
and they are then targeted to their appropriate intracellular site.
Secretion  of  protein  from  acinar  cells  is  a  regulated  process.   At  rest, 
secretion occurs at a low or basal rate, but this rate can be markedly increased by 
secretory  stimulation  that,  in  the  pancreas,  is  both  hormonal  and  neural. 
Pancreatic acinar cells can express receptors for acetylcholine.  Cholecystokinin, 
secretin,  and  vasoactive  intestinal  peptide.  Stimulation  of  secretion  by  either 
acetylcholine  or  cholecystokinin  has  been  shown  to  involve  activation  of 
phospholipase C, generation of inositol triphosphate and diacyl glycerol, and a rise 
in  intracellular  ionized  calcium  levels  that,  by  yet  unidentified  mechanisms, 
upregulates the rate of secretory protein discharge at the apical cell membrane. In 
contrast,  secretion  and  vasoactive  intestinal  peptide  activate  adenylate  cyclase, 
increase cellular levels of cyclic adenosine monophosphate (AMP), and activate 
protein kinase A.  This also leads to protein secretion at the apical pole.  Recent 
studies  indicate  that  human  acinar  cells  may  not  possess  receptors  for 
cholecystokinin and that , in humans, cholecystokinin stimulation of secretion is 
mediated by intrapancreatic nerves that express cholecystokinin receptors.
Electrolyte Secretion :
Although  stimulation  of  acinar  cells  results  in  the  secretion  of  a  small 
amount of serum like fluid, most of the fluid and electrolytes secreted from the 
pancreas arise from duct cells.  The earliest step in duct cell electrolyte secretion 
involves diffusion of circulating carbon dioxide into the duct cell, and that carbon 
dioxide is hydrated by carbonic anhydrase to yield carbonic acid.  Subsequently, 
the  carbonic  acid dissociates  into protons  and bicarbonates  ions.   The protons 
diffuse out of the cell and are carried away in the circulation while the bicarbonate 
remains  inside  the  cell.   The  fluid  and electrolyte  secretagogue secretion acts, 
through a cyclic AMP mediated process,  to stimulate chloride secretion, at  the 
apical  cell  surface,  through  cystic  fibrosis  transmembrane  regulator  (chloride) 
channels.  Then, through an apical chloride-bicarbonate exchanger, the actively 
secreted chloride is taken up again by the duct cell in exchange for bicarbonate. 
Taken together the result of these events is the secretion of a bicarbonate rich fluid 
into the duct and the discharge, into the circulation, of protons.  In the absence of 
secretin stimulation, pancreatic juice has a more plasma like composition because 
it  is  composed  primarily  of  acinar  cell  secretions  and  there  is  little  duct  cell 
secretion  of  chloride  to  permit  exchange  with  bicarbonate.   With  secretin 
stimulation,  chloride  secretion  is  increased,  flow  rates  rise,  and  chloride 
bicarbonate  exchange  results  in  juice  that  is  rich  in  bicarbonate  and  poor  in 
chloride.
Integrated Physiology :
 During  the  resting  (interdigestive)  phase  of  gastrointestinal  function, 
pancreatic  secretion  is  minimal  and  may  be  as  low as  2% of  that  noted  with 
maximal stimulation.  The pancreatic response to a meal is a three phase process 
that  includes  a  cephalic  phase,  a  gastric  phase,  and  an  intestinal  phase.   The 
cephalic  phase,  accounting  for  10%  to  15%  of  meal  stimulated  pancreatic 
secretion, reflects the response  to the sight, smell, or taste of food. It is believed to 
be  almost  exclusively  mediated  by  peripherally  relased  acetycholine,  which 
directly stimulates pancreatic secretion of enzymes and gastric secretion of acid. 
The  acid  indirectly  stimulates  pancreatic  secretion  of  fluid  and electrolytes  by 
causing  duodenal  acidification  and  secretin  release.   The  gastric  phase  of 
pancreatic  secretion, accounting for 10% to 15% of meal-stimulated pancreatic 
secretion reflects the response to gastric distention and the entry of food into the 
stomach.  These events can cause release of gastrin and stimulate vagal afferents. 
By  binding  to  cholecystokinin  receptors,  gastrin  is  itself  a  weak  stimulant  of 
pancreatic enzyme secretion.  Vagal stimulation also increases enzyme secretion.
More important, however gastrin and vagal stimulation cause gastric acid 
secretion,  and this leads to duodenal  acidification,  release of  secretin from the 
duodenum, and pancreatic secretion of fluid and electrolytes.  The intestinal phase 
of pancreatic secretion reflects the response to food and gastric secretions entering 
the proximal intestine.  Acidification of the duodenum and the presence of bile in 
the  duodenum  promote  secretin  release.   In  addition,  in  the  duodenum  and 
proximal small intestine, the presence of fat and protein, as well as their partial 
breakdown  products,  stimulates  the  release  of  cholecystokinin,  and  this 
cholecystokinin  stimulates  enzyme  secretion  from acinar  cells.   The  intestinal 
phase  of  pancreatic  secretion  accounts  for  70%  to  75%  of  meal  stimulated 
pancreatic secretion.
ETIOLOGY OF CHRONIC PANCREATITIS
Newer  classification  systems,  such  as  the  TIGAR-O,  categorize  chronic 
pancreatitis based on the various known etiologic factors and mechanisms that are 
jointly considered risk modifiers (TIGAR-O) toxic, metabolic, idiopathic, genetic, 
autoimmune,  recurrent severe, obstructive.
We discuss the various causes of chronic pancreatitis based on the TIGAR-O 
system.
Multiple toxic and metabolic etiologies involved in chronic pancreatitis. The 
association of alcohol and chronic pancreatitis was first described by COMFORT 
and  associates  in  1946.   Alcohol  is  still  the  most  common  cause  of  chronic 
pancreatitis in Western industrialized countries, but only 5% to 10% of alcoholics 
develop clinically apparent chronic pancreatitis, and at autopsy  10% to 20% of 
alcoholics are found to have evidence of chronic pancreatitis.
Because  only  a  fraction  of  alcoholics  develop  chronic  pancreatitis, 
involvements  of  other factors  are actively being investigated.  Several  evidence 
have  shown  that  in  addition  to  direct  effects  of  alcohol,  various  predisposing 
factors,  including  genetics,  smoking,  intestinal  infection,  high  fat  diet, 
compromised immune function, gallstones, gender, hormonal factors and drinking 
patterns may render the pancreas more susceptible to alcohol induced tissue injury.
Smoking also is  independently  associated with increased risk for  chronic 
pancreatitis.  Chronic pancreatitis induced by smoking is particularly associated 
with pancreatic calcification.  By mechanisms similar to alcohol, tobacco produces 
alterations in the secretion and composition of pancreatic juice mainly as a result 
of decreased pancreatic juice and bicarbonate secretion and induction of oxidative 
stress.
Calcium  plays  a  central  role  in  trypsinogen  secretion  and  trypsin 
stabilization.   Hypercalcemia  caused  by  primary  or  secondary 
hyperparathyroidism results  in recurrent  acute pancreatitis,  which progresses to 
chronic  pancreatitis,  likely  owing  to  trypsinogen  activation,  which  results  in 
necrosis and fibrosis of the parenchyma.
Increased serum calcium concentration is believed to induce direct damage 
to  acinar  cells,  and  increased  secretion  of  calcium results  in  intraductal  stone 
formation.  Hypercalcemia also seems to modify pancreatic secretion, leading to 
protein plug formation.
Idiopathic :
Thirty percent of patients with chronic pancreatitis do not have known risk 
factors for chronic pancreatitis and are considered to have idiopathic pancreatitis. 
Mutations of the serine protease inhibitor, Kazal type 1 (spink 1) gene in 25% of 
patients with idiopathic  chronic pancreatitis.  Based on the bimodal age of onset 
of  the  clinical  symptoms,  idiopathic  pancreatitis  is  separated  into  two  distinct 
entities.  Early onset  idiopathic chronic pancreatitis presents during the first  2 
decades  of  life  with  abdominal  pain   being  the  predominant  clinical  feature, 
whereas  pancreatic  calcifications  and  exocrine  and  endocrine  pancreatic 
insufficiency are rare at the time of first diagnosis.
In  contrast,  the  clinical  presentation  of  late  onset  idiopathic  chronic 
pancreatitis is in patients in their 40s, usually following a rather painless course, 
but associated with significant exocrine and endocrine pancreatic insufficiency and 
pancreatic calcifications.
Tropical or nutritional pancreatitis is considered a form of idiopathic chronic 
pancreatitis.  It is the most common form of chronic pancreatitis in certain parts of 
the world, such as India, sub-Saharan Africa, and Brazil, and affects children and 
young  adults  (Schneider  et  al  2002).   The  disease  is  subdivided  into  tropical 
calcific  pancreatitis,  which  is  characterized  by  severe  recurrent  and  chronic 
abnormal  pain  and  extensive  pancreatic  calcifications,  and  fibrocalculous 
pancreatic  diabetes,  which  is  characterized  by  significant  pancreatic  endocrine 
insufficiency.   This  form of  chronic  pancreatitis  is  related to  mutations  in  the 
SPINK 1 gene.
Strong  association  between  cystic  fibrosis  transmembrane  conductance 
regular  (CFTR) mutations  and idiopathic  chronic  pancreatitis.  One  third of  all 
patients with idiopathic chronic pancreatitis have CFTR mutations.
Leading pancreatologists speculate that most chronic pancreatitis might be a 
genetic disease with multifactorial triggering factors.
Genetic : 
Until  more  recently  few  data  existed  on  the  genetic  basis  of  chronic 
pancreatitis.  The only known hereditary form of chronic pancreatic insufficiency 
that was well studied was cystic fibrosis.
Research has focused on the SPINK1-N34S gene mutation, which also is 
associated  closely  with  tropical  (50%),  alcoholic  (6%),  or  idiopathic  (20%)  c 
chronic pancreatitis.
One of the major discoveries in chronic pancreatitis was the description of 
the point  mutation in patients with autosomal dominant  hereditary pancreatitis. 
Several  variants  of  the mutation of the cationic trypsinogen gene all  lead to a 
malfunction  of  trypsinogen.   Hereditary  pancreatitis  presents  typically  in  a 
bimodal  pattern  of  childhood  and  adulthood.   Hereditary  pancreatitis  is  an 
autosomal  dominant  disease  associated  with  trypsinogen  gene  mutations  that 
carries an 80% penetrance.
Despite  great  advances  in  the  knowledge  of  genetics  in  pancreatitis, 
currently it is advised to evaluate for mutations only in patients with hereditary 
pancreatitis.
Autoimmune  :
Autoimmune chronic pancreatitis (AIP) is a rare but distinct form of chronic 
pancreatitis that is associated with autoimmune features.  AIP is characterized by 
specific histopathologic and immunologic features.  The morphologic hall marks 
are  periductal  infiltration  by  lymphocytes  and  plasma  cells  and  granulocytic 
epithelial lesions with consequent destruction of the duct epithelium and venulitis.
The pathogenesis of AIP values a cellular CD4+ and CD8+ T cells) and 
humoral immune mediated attack of the ductal cells and pancreatic ducts resulting 
in  cytokine  mediated  inflammation  and  periductular  fibrosis,  which  leads  to 
obstruction of the pancreatic ducts.
AIP  is  characterized  clinically  by  minimal  abdominal  pain  and  diffuse 
enlargement of the pancreas  without calcifications or pseudocysts.
On laboratory  examination,  these  patients  have  hypergammaglobulinemia 
and autoantibodies, such as antinuclear and anti-smooth muscle antibodies.
Obstructive :
Obstruction of the main pancreatic duct is well known to result in chronic 
pancreatitis.  The  most common etiologies include scars of the pancreatic duct, 
tumors of the ampulla of Vater and head of the pancreas, and trauma.  
Main pancreatic duct obstruction may lead to stagnation and stone formation 
of  pancreatic  juice  (stone  and  duct  obstruction  theory)  or  acute  recurrent 
pancreatitis  and periductular fibrosis (necrosis fibrosis theory)  Histopathologic 
characteristics of human chronic pancreatitis  resulting from obstruction include 
uniform  distribution  of  interlobular  and  intralobular  fibrosis  and  marked 
destruction of  the  exocrine  parenchyma in the  territory  of  obstruction,  without 
significant protein plugs and calcifications.
Chronic pancreatitis results from plugging of the pancreatic duct. The origin 
of chronic pancreatitis was within the lumen of the pancreatic ductules in contrast 
to  the  origins  of  acute  pancreatitis  which  tends  to  be  inside  the  acinar  cell. 
Increased lithogenicity of pancreatic fluid leads to the formation of eosinophilic 
proteinaceous aggregates, which precipitate and obstruct the pancreatic ductules.
Alcochol  decreases  the  formation   and  the  secretion  of  pancreatic  juice, 
making  it  more  viscous  ;  low  in  bicarbonate  ;  rich  in  protein,  enzymes  and 
calclium crystals ; and deficient in lithostatin.
Alcohol  also  has  been  shown  to  mediate  the  release  of  gastrointestinal 
hormones by increasing cholecystokinin releasing factor, which affects pancreatic 
juice formation and flow.  The pancreatic stones and plugs are believed to produce 
ulceration  of  the  ductal  epithelial  cells  resulting  in  inflammation,  fibrosis, 
obstruction, stasis and further stone formation.
Mechanism of chronic pancreatitis was a dysregulation and overactivity of 
the hepatic mixed function oxidases leading to oxidative stress.  This theory places 
the acinar cell at the major area of injury by oxidative stress, usually as a result of 
steady exposure of xenoiotics that induce the cytochrome P-450 enzymatic system, 
while depleting glutathione.
Pancreatitis  is  triggered  through  interference  of  the  methionine  to 
glutathione transsulfuration pathway, resulting in diversion of free radicals in to 
the pancreatic tissue, with consequent activation of inflammation and fibrosis of 
the  ductules  with  low  flow  of  pancreatic  juice,  inhibition  of  lithostatin,  and 
precipitation  of  proteins  and  calcium  (Braganza  1998  ;  Wilson  et  al,  1990). 
Alcohol  also  may  contribute  to  increase  the  oxidative  stress  resulting  from 
depletion of scavengers, such as selenium, vitamin E and C  and riboflavin, and 
help to induce or propagate the damage.
Alcohol and its toxic metabolites cause accumulation of intracellular lipids 
and  fatty  acid  ethyl  esters,  which  produce  damage  to  the  acinar  cell.   The 
alterations of intracellular lipid metabolism lead to fatty degeneration, apoptosis 
and  scarring  of  the  pancreatic  parenchyma  with  impairment  of  the  pancreatic 
microcirculation.
It was shown that these fat cells exists in the human pancreas, can migrate 
into  the  periacinar  spaces,  and  are  activated  by  alcohol  and  acetyl  aldehyde, 
transforming into scar producing cells. The necrosis fibrosis hypothesis views the 
development  and  course  of  chronic  pancreatitis  as  a  consequence  of  severe 
pancreatitis,  emphasizing  that  fibrosis  is  a  late  development  resulting  from 
repeated  attacks  of  acute  (alcoholic)  pancreatitis,  which  initially  lead  to 
inflammation and necrosis.
The necrosis fibrosis hypothesis has significant  supporting evidence from 
epidemiologic and large follow up studies, which showed that chronic pancreatitis 
results from recurrent attacks of acute pancreatitis.
The  recurrent  attacks  of  acute  pancreatitis  in  hereditary  pancreatitis  also 
support  the  necrosis  fibrosis  hypothesis.   One  important  aspect  that  partially 
negates  this  hypothesis  is  the  fact  that  the  type  of  fibrosis  that  follows  acute 
attacks of pancreatitis involves short lived collagen type III and procollagen type 
IV and not the long lasting collagen types I and IV (Casini et al 2000).
The primary pathogenic factor leading to chronic pancreatitis is an outflow 
obstruction likely resulting from duct inflammation, destruction and fibrosis which 
likely are the result of an immunologic attacks on a specific genetic, structural or 
acquired antigen of the periductular epithelium.  The target of this attack may be 
some specific genetic or acquired antigen on the duct epithelium.
Chronic pancreatitis seems to be an autoimmune or duct destroying disease, 
analogous  to  primary  sclerosing  cholangitis.  The  assumption  is  supported  by 
several observations, such as the radiologic and histologic similarity of chronic 
pancreatitis  and  primary  sclerosing  cholangitis,  the  activation  of  cytotoxic 
T.lymphocytes in the periductular areas of the pancreas in patients with alcoholic 
chronic  pancreatitis,  and the  occasional  association  of  chronic  pancreatitis  and 
primary sclerosing cholangitis.
The SAPE hypothesis tries to provide a “final common pathway” for the 
many  etiologies  for  pancreatitis.   The  basic  aspect  is  that  there  needs  to  be 
susceptibility (genetic or through ongoing insult, such as alcohol toxicity).  The 
critical sentinel event appears and triggers the process causing acute and chronic 
pancreatitis.  Further activation of the immunologic system and the stellate cells 
propagates chronic pancreatitis, and the end result is fibrosis and calcifications.
This hypothesis has the merits of placing several of the previous theories 
under “one umbrella”.
                          
                        MATERIALS AND METHODS
This prospective study of chronic pancreatitis was conducted in 55 patients 
admitted  in  GRH,  Madurai,  General  Surgery  and  Surgical  Gastroentereology 
department from 2006 to 2008.
Informed consent was obtained from all patient who were included in the study.
Inclusion Criteria :
Patient  with chronic pancreatitis  presenting with refractory pain abdomen 
requiring surgical intervention were included in the study.
Exclusion criteria :
Patient with chronic pancreatitis  who require surgical  resection procedure 
are excluded from the study.
Study Design :
Each  patient  in  the  study  was  subjected  to  detailed  clinical  examination 
correlating with a detail history.  Investigations in the form of routine hemogram, 
LFT,  PFT  and  imaging  studies  like  X  rays,  USG,  CT  abdomen  and  other 
investigations relevant to the suspected disease system involved were done.  From 
the above clinical data and imaging studies chronic pancreatitis was diagnosed. 
Patients  who  requires  surgical  intervention  were  prepared  and  taken  up  for 
drainage  procedure  after  satisfying  the  inclusion  and  exclusion  criteria.   The 
results were tabulated and analysed.
ANALYSIS
Age Distribution :
Table : 1
Age group No.of cases Percentage
1 – 10 - -
11 – 20 16 29 %
21 – 30 14 25 %
31 – 40 12 22 %
41 – 50 10 18%
51 – 60 3 6%
Total 55 100 %
Sex Distribution :
Table - 2
Sex No.of cases Percentage
Male 32 58 %
Female 23 42 %
Total 55 100 %
Male :  Female    =    1.3  :  1
Clinical Data
Table – 3
Clinical Data No.of cases Percentage
Pain Abdomen 55 100%
Diabetes 18 32%
Steatorrhea 3 6%
Weight loss 14 26%
Alcoholic 15 27 %
Smoker 17 30 %
IGTT 18 32%
     
          IGTT – Impaired Glucose Tolerance Test
Surgical Outcome :
Table - 4
Pain relief No.of cases Percentage
Yes 35 63.6 %
No 20 36.4 %
Clinical features- Chronic pancreatitis
                                Table - 5
No.of Patients 55
Mean Age 35
Sex (M : F) 1.3  :  1
Pain 100%
Diabetes 32%
Steatorrhea 6%
                                        DISCUSSION
Age Distribution :
The youngest patient in this study was 12 years old female and oldest patient 
was 59 years old male.  Most of the patients presented in the 2nd decade of life in 
this study group ie. 11 to 20 years (29%).
Sex Distribution :
Males are affected more than female patient in the ratio of 1.3:  1 in this 
study group.
Etiological distribution :
In this study (27%) of the patients are alcoholic.  The etiological factor in 
this  group  of  patients  are  undetermined  that  may  be  attributed  to  nutritional, 
idiopathic, hereditary etc.
Chronic  alcoholism is  one  of  the  important  etiological  factor  in  chronic 
pancreatitis.  Alcohol abuse also affects the clinical feature, course and prognosis 
of disease.  In upto 70% of adult patient chronic pancreatitis appears to be caused 
by alcoholism.  This form is more common in men than women between age of 30 
to 40.
Heriditary pancreatitis usually begins in childhood but may not be diagnosed 
for  several  years.   A determining factor  is  two or  more  family  members  with 
pancreatitis in more than one generation.  
In our series 30% of the patients were smoker.  Smoking is a recognized risk 
factor associated with chronic pancreatitis.  It also accelerates the progression of 
the  disease.   It  is  now  recognized  as  an  independent  risk  factor  for  chronic 
pancreatitis.
Idiopathic  chronic  pancreatitis  was  the  most  common  from followed  by 
alcoholic  pancreatitis  in  India.   This  was published by Amritha Institute  of 
Medical  Science,  Cochin,  India.   (chronic  pancreatitis  :  prospective 
nationwide study of 1086 subjects from India on Sep 2008 in pub-med.)
Clinical Presentation :
In our study common clinical presentation was recurrent episodes of pain in 
epigastrium  radiating  to  back,  other  features  include  diabetes,  weight  loss, 
steatorrhea, anorexia etc.
For most patient with chronic pancreatitis abdominal pain is the presenting 
symptom.   Either  the  patient’s  age  or  the  etiology  of  the  disease  has  some 
influence  in  it.   Most  patients  experience  intermittent  attack  of  pain  at 
unpredictable intervals, while minority of patients experience chronic pain. The 
natural history of pain in chronic pancreatitis is highly variable.
Other symptoms include diarrhea and weight loss.  This may be due either to 
fear of eating (post prandial exacerbation of pain) or due to pancreatic exocrine 
insufficiency and steatorrhea).
A small percentage of patients (20%) have painless chronic pancreatitis, and 
present with signs and symptoms of exocrine and endocrine insufficiency.
Diagnosis of chronic pancreatitis :
In  this  study  diagnosis  of  chronic  pancreatitis  is  based  on  the  thorough 
history, physical examination laboratory data or imaging abnormalities.  Imaging 
methods done in this study were plain abdominal radiographs which revealed the 
presence of focal or diffuse pancreatic calcifications in 25 to 30% of the cases, 
transabdominal ultrasound which showed pancreatic duct dilatation irregularly of 
main pancreatic duct, loss or reduction of pancreatic parenchymal echogenicity, 
calculi  and calcifications.   CT scan abdomen findings  showed pancreatic  duct 
dilation, calcification and cystic lesions.
Imaging, modalities like ERCP and EUS are more sensitive and specific in 
diagnosis of chronic pancreatitis.  They are expensive and the cost factor and non 
availability remains a constrain.
Diagnosis of chronic pancreatitis is based on a thorough history and physical 
examination, laboratory data and imaging studies.  Today pancreatic function tests 
play a minor and only complementary role in the diagnosis of chronic pancreatitis. 
The two main reasons for this minor role are that
i) Non invasive test of exocrine pancreatic function show high sensitivity 
only in advanced stage of chronic pancreatitis.
ii) Clinical manifestations of an exocrine pancreatic insufficiency occurs late 
in  the  course  of  disease  after  approx 90% of  exocrine  parenchyma is 
destroyed.
Exocrine pancreatic function test :
Invasive test :
1. Secretin cerulin test
2. Lundh test
Non invasive test :
1. Bentiranide test
2. PLT
3. FE – 1 (Stool test)
Endocrine pancreatic function test :
1. Fasting blood sugar
2. Oral glucose tolerance test
Imaging methods :
Non  invasive  imaging  methods  are  method  of  choice  for  diagnosis  of 
chronic  pancreatitis  in  clinical  situations.   Currently  ERCP  is  still  the  “Gold 
standard” among the all imaging methods.  But in the future it may be replaced by 
further significant refinement of magnetic resonance imaging cholangiography.
Plain Abdominal Radiography :
Shows focal or diffuse pancreatic calcifications in 30 to 40% of cases makes 
the diagnosis of advanced chronic pancreatitis.
Transabdominal USG is an essential tool to visualize the entire pancreas.  It 
is inexpensive, simple, noninvasive, widely distributed, well tolerated and often 
first  imaging method in  patient  with abdominal  complaint.   In  routine  clinical 
situation,  USG  is  the  easiest  method  to  detect  the  complication  of  chronic 
pancreatitis and to follow patients with chronic pancreatitis. Use of ultrasound for 
diagnosing chronic pancreatitis is limited to advanced stage.
CT scan is  as specific  as  ultrasound but  more  sensitive.  CT scan cannot 
detect  early  parenchymal  changes  and  effects  on  small  pancreatic  ducts,  but 
advanced  stages  and  complications  of  the  disease  can  be  evaluated  with  high 
reliability. CT is most sensitive to detect calculi. Chronic pancreatitis is excellent 
method to detect advanced stage but not for early stage of chronic pancreatitis.
ERCP is still “gold standard” imaging modality.  An ERCP staging system 
based in pancreatic ductal changes has been developed for diagnosis of chronic 
pancreatitis which was published in 1984 as the Cambridge criteria.  Changes of 
early chronic pancreatitis may not be seen on ERCP.  ERCP is invasive method 
(post ERCP pancreatitis of 3 to 7%), expensive, specialised equipment and trained 
personal are necessary to perform the produce and to interpret the pancreatograms. 
ERCP may be useful in distinguishing chronic pancreatitis from pancreatic cancer. 
The advantage of ERCP are standardization and evaluation method in multi center 
trials and possibility of intervention.  The advantages are complications, costs and 
invasiveness.
Magnetic Resonance Imaging pancreatography an imaging method is created 
that enables clinicians to visualize ductal of chronic pancreatitis.  The advantage of 
this modality is noninvasiveness.  The major disadvantage is that changes of side 
branches are not visualized with same accuracy as in ERCP and not sensitive to 
detect early stages of chronic pancreatitis.
Endoscopic ultrasound visualize the pancreatic duct and the parenchyma and 
has the ability to detect chronic pancreatitis in patients with early stages of the 
disease and with advanced chronic pancreatitis.  Major advantage of EUS when 
compared to other imaging modalities is that its ability to detect early stages of 
chronic pancreatitis without any complications.  The disadvantage of this method 
is need for expert EUS endoscopist and dedicated EUS unit.
MANAGEMENT :
In this study patients with refractory intractable abdominal pain are selected 
and taken up for surgical drainage procedure.  The most common surgical drainage 
procedure done was modified peustows  LPJ.
The over all surgical outcome in the form of pain relief in the study group 
was approximately 64%.  In the study group out of 55, 20 (36%) patients in the 
follow up period came with recurrence of pain.
The  treatment  of  chronic  pancreatitis  is  complex  and  often  an 
interdisciplinary  approach  is  indicated  with  the  possibility  of  conservative 
endoscopic and Surgical therapy.
Conservative treatment :
A major  component  of  the  conservative  treatment  is  the  management  of 
complications.  This complex interaction requires individualization in nearly every 
case. Hence the importance of the team approach.
Pancreatic exocrine enzyme supplemention :
When weight loss or steatorrhea (15g/day) or both develop supplementation 
is indicated.  The main goal is to ensure the optimal amounts of lipase reach the 
duodenum  together  with  the  delivered  food.   With  the  currently  available 
pancreatic enzymes supplement preparation Azotorrhea can be abolished, whereas 
steatorrhea can be reduced but not totally corrected.  Side effects are rare except 
soreness  of  mouth,  perianal  irritation,  abdominal  pain,  diarrhea,  constipation, 
allergic reaction and fibrosing colonopathy in cystic firbrosis patiet. Dose of lipase 
: 2500 u lipase / kg body weight per meal.
Conservative treatment of pain :
Pain  significantly  reduces  patient’s  quality  of  life  and  so  main  goals  of 
conservative treatment is to manage it, Medical treatment is generally the first line 
therapy in patients with painful chronic pancreatitis.
Alcohol  abstinence  and  diet  advice  are  recommended  but  only  50%  of 
patients achieve pain relief.
Analgesies such as non narcotics and NSAID agents are recommended as 
first step.  An antidepressant may have an effect on pain and increase the effect of 
opiates.
Interventional endoscopy and lithotripsy seems to be beneficial in cases with 
man pancreatic duct stenosis and obstructing calculi. Further studies are needed to 
evaluate the effect of pancreatic duct interventions on pancreatic pain.
About 80% of patient  with chronic pancreatitis  can be  manage by direct 
recommendations and pancreatic enzyme supplements.  10 to 15% of patients need 
oral supplements, 5% need enteral tube feeding and approximately 1% need total 
parenteral nutrition.  Reduction of steatorrhea and supplementation of calories are 
the main goals of nutritional therapy in chronic pancreatitis. Treatment of exocrine 
insufficiency  starts  with  dietary  recommendations  and  pancreatic  enzyme 
supplementation.
Endoscopic Treatment :
1. Decompression  of  pancreatic  cysts  by  transgastric,  transduodenal,  and 
transpupillary  approaches  are  preferred  procedures  in  case  of 
interventional  treatment  for  pancreatic  pseudocyst.   In  case  of  poor 
anatomic conditions or if there is contra indications for endoscopy patient 
should be referred to a surgeon.
2. Common  bile  duct  stenting  is  a  another  indication  of  endoscopic 
intervention.  A team approach between endoscopist and surgeon should 
guide the treatment of CBD stenosis in patient with chronic pancreatitis. 
The descision depends on patient  age,  comorbidities   and cause  of  the 
stricture.  Major limitations of endoscopic intervention are stent clogging, 
migration and cholangitis.
SURGERY :
The surgical treatment of chronic pancreatitis is based on two main concepts. 
Preservations of tissue via drainage operation is the goal for protection against 
further loss of pancreatic function. Resective procedures are performed in the case 
of  a  non  dilated  pancreatic  duct,  if  the  pancreatic  head  is  enlarged  or  if  a 
pancreatic carcinoma is suspected in addition to chronic pancreatitis.
Drainage procedure :
Pancreatic  duct  spinceterotomy  was  one  of  the  first  surgical  procedures 
proposed for patient with chronic pancreatitis and (stenosis) at the papilla of vater. 
This procedure was recognized as a dangerous approach and lower success rates 
for amelioration of pain.
More  successful  in  patient  with  chronic  pancreatitis  and  with  dilated 
pancreatic duct is the original Puestow procedure or its modification by Partington 
and Rochelle. The procedure include resection of the tail of pancreas followed by 
a longitudinal incision along the body of the pancreas and an anastomosis with a 
Roux en Y lop of jejunum.  The modification of Partington and Rochelle is the 
elimination of the resection of the pancreatic tail.  Patient with a dominant mass in 
the head of the pancreas and a dilated pancreatic duct do not profit from a drainage 
procedure only. In addition to the drainage approach Beger and Izbicki proposed 
excavation of the head of the pancreas or the V shaped exacavation of the body 
along the main pancreatic duct followed by a pancreatico jejunostomy.
Resection procedures :
Whipple’s procedure, Pylorus preserving pancreatico duodenectomy, Beger 
procedure, Berne modification of the Beger procedure (DPPHR) are the various 
resection procedured with merits and demerits.
Beger’s procedure (DPPHR) preserved the duodenum when compared to the 
whipples  procedure,  which was the  standard procedure  in  patient  with chronic 
pancreatitis for a long time.  Patient who underwent Beger Procedure had greater 
weight  gain,  better  glucose  tolerance  and  high  insulin  secretion  capacity. 
Improved pain status, lower frequency of acute episodes of chronic pancreatitis, 
rate  need  for  further  hospitilization,  low  early  and  late  mortality  rates  and 
restoration of quality of life, DPPHR seems to be able to delay the natural course 
of the chronic pancreatitis.  
Frey procedure which involve local pancreatic head excision. combined with 
longitudinal pancreatico jejunostomy can be considered as a standard procedure in 
chronic pancreatitis and has under gone evaluation in multiple trails, confirming 
its effectiveness as a surgical procedure for chronic pancreatitis.
Pancreatic  left  resection  and  central  pancreatectomy  (segmentectomy)  in 
chronic pancreatitis are procedure which further studies to prove the effectiveness 
in chronic pancreatitis. 
Laproscopic Surgery :
              Laproscopic surgery can be performed successfully to manage patients 
with distal chronic pancreatitis and patients with pancreatic pseudocyst. Analysis 
of literature suggests that laparoscopic resection of the left part of pancreas, when 
indicated in selected groups, produces excellent results, pain relief was achieved in 
72%  of  patients.  Laproscopic  intraluminal  cystogastrostomy  and  laproscopic 
anterior  cystogastrostomy  are  safe  and  effective  methods  to  treat  symptomatic 
large pseudocyst (> 6cm in diameter)
Definite evidence from large RCT or meta analysis is still missing regarding 
which surgical regimen is superior in patient with chronic pancreatitis.  Many still 
unresolved questions in the surgical treatment of chronic pancreatitis have to be 
answered in future randomized controlled trails.
                                 
CONCLUSION
In this prospective study which was conducted in 55 patients with chronic 
pancreatitis at GRH, Madurai between 2006 to 2008, the following conclusions 
were derived out.
1. Most of the patients presented in their 2nd decade of life and mean age is 
35.
2. Males are affected more than females in the ratio of 1.3 : 1
3. In this study 27% of the patients are alcoholic the etiological factor in this 
group of patients are undetermined, that may be attributed to Nutritional, 
Idiopathic, hereditary etc.  
4. Recurrent episodes of pain in epigastrium radiating to back is the most 
common presentation in this study group. Other features include diabetes, 
weight loss, anorexia steatorrhea etc.
5. Modified Puestow’s is the most commonly performed surgical drainage 
procedure and has good results in pain relief post operatively to 64% in 
this study group.
                            
PROFORMA
Name  : Age / Sex :
Place  : Ward : IP No.
Clinical Data :                                
1. Abdominal pain
2. Diabetes
3. Steatorrhea
4. Loss of weight
5. Jaundice
6. Physical findings
Epigastric tenderness
Epigastric Mass
Hepatomegaly
Ascites
Investigations :
1. Blood – Sugar, Urea, Creatinine
2. Serum Amylase, lipase
3. Oral glucose tolerance test
4. Haemogram
5. Liver function test
6. pancreatic function test
Imaging 
1. Plain X ray – abdomen
2. Ultra sound – abdomen
3. CT Scan – abdomen
4. ERCP
5. MRCP
Treatment 
Surgery – Drainage procedure
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